167 related articles for article (PubMed ID: 25074500)
1. Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists.
Petrovic-Stanojevic N; Topic A; Nikolic A; Stankovic M; Dopudja-Pantic V; Milenkovic B; Radojkovic D
Mol Diagn Ther; 2014 Dec; 18(6):639-46. PubMed ID: 25074500
[TBL] [Abstract][Full Text] [Related]
2. ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis.
Karimi L; Vijverberg SJ; Engelkes M; Hernandez-Pacheco N; Farzan N; Soares P; Pino-Yanes M; Jorgensen AL; Eng C; Mukhopadhyay S; Schieck M; Kabesch M; Burchard EG; Chew FT; Sio YY; Potočnik U; Gorenjak M; Hawcutt DB; Palmer CN; Turner S; Janssens HM; Maitland-van der Zee AH; Verhamme KMC;
Clin Exp Allergy; 2021 Sep; 51(9):1157-1171. PubMed ID: 34128573
[TBL] [Abstract][Full Text] [Related]
3. Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response.
Ambrose HJ; Lawrance RM; Cresswell CJ; Goldman M; Meyers DA; Bleecker ER
Respir Res; 2012 May; 13(1):37. PubMed ID: 22559839
[TBL] [Abstract][Full Text] [Related]
4. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China.
Fu WP; Zhao ZH; Zhong L; Sun C; Fang LZ; Liu L; Zhang JQ; Wang L; Shu JK; Wang XM; Dai LM
Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278
[TBL] [Abstract][Full Text] [Related]
5. Beta 2 Adrenergic Receptor Genetic Polymorphisms in Bronchial Asthma: Relationship to Disease Risk, Severity, and Treatment Response.
Mohamed-Hussein AAR; Sayed SS; Eldien HMS; Assar AM; Yehia FE
Lung; 2018 Dec; 196(6):673-680. PubMed ID: 30178312
[TBL] [Abstract][Full Text] [Related]
6. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
Ortega VE; Hawkins GA; Moore WC; Hastie AT; Ampleford EJ; Busse WW; Castro M; Chardon D; Erzurum SC; Israel E; Montealegre F; Wenzel SE; Peters SP; Meyers DA; Bleecker ER
Lancet Respir Med; 2014 Mar; 2(3):204-13. PubMed ID: 24621682
[TBL] [Abstract][Full Text] [Related]
7. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
[TBL] [Abstract][Full Text] [Related]
9. Possible protective effects of the Glu27 allele of beta2-adrenergic receptor polymorphism in Thai asthmatic patients.
Limsuwan T; Thakkinstian A; Verasertniyom O; Vanichapuntu M; Attia J; Janwityanujit S; Nantiruj K
Asian Pac J Allergy Immunol; 2010; 28(2-3):107-14. PubMed ID: 21038778
[TBL] [Abstract][Full Text] [Related]
10. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.
Kim SH; Ye YM; Hur GY; Lee HY; Jee YK; Lee SH; Holloway JW; Park HS
Yonsei Med J; 2009 Apr; 50(2):182-8. PubMed ID: 19430548
[TBL] [Abstract][Full Text] [Related]
12. Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort.
Zuurhout MJ; Vijverberg SJ; Raaijmakers JA; Koenderman L; Postma DS; Koppelman GH; Maitland-van der Zee AH
Pharmacogenomics; 2013 Dec; 14(16):1965-71. PubMed ID: 24279851
[TBL] [Abstract][Full Text] [Related]
13. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
[TBL] [Abstract][Full Text] [Related]
14. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
15. An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population.
Akparova A; Aripova A; Abishev M; Kazhiyakhmetova B; Pirmanova A; Bersimbaev R
Clin Respir J; 2020 Jun; 14(6):514-520. PubMed ID: 32034992
[TBL] [Abstract][Full Text] [Related]
16. Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.
Turner S; Francis B; Vijverberg S; Pino-Yanes M; Maitland-van der Zee AH; Basu K; Bignell L; Mukhopadhyay S; Tavendale R; Palmer C; Hawcutt D; Pirmohamed M; Burchard EG; Lipworth B;
J Allergy Clin Immunol; 2016 Jul; 138(1):107-113.e5. PubMed ID: 26774659
[TBL] [Abstract][Full Text] [Related]
17. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
19. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
20. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
